Nara Organics has issued a recall of its Whole Milk Organic Powdered Infant Formula sold at Target and online due to a multistate outbreak of infant botulism. The U.S. Food and Drug Administration announced that three infants, aged 2 to 5 months, were hospitalized in California, Pennsylvania, and Washington after consuming the product. The formula is manufactured in Europe and constitutes less than 1% of all infant formula sold in the United States.
Infant botulism is a rare but serious illness that affects babies under one year old, whose digestive systems are not fully developed. The condition arises when infants ingest bacteria spores that produce toxins in their intestines. Symptoms include constipation, poor feeding, drooping eyelids, weak muscle tone, and difficulty swallowing. The sole treatment is BabyBIG, an FDA-approved intravenous medication made from blood plasma of people immunized against botulism.
The Centers for Disease Control and Prevention has urged consumers to stop using the recalled formula immediately. Caregivers are advised to take a photograph of the opened product, record the lot number and use-by date, and monitor infants for symptoms. If no symptoms develop within a month, caregivers should discard the formula.
Nara Organics is cooperating with the FDA, CDC, and state health authorities to investigate the outbreak's cause. The company stated it is taking "aggressive action" to ensure the safety of its customers. Consumers who purchased the formula from Nara.com between May and June 2026 will receive an automatic refund. Those who bought the product at Target can return it for a refund or request one through the retailer's website. The affected product lots are 709125280E14F2, 709125288E14F2, and 708125174E14F2.
The FDA has not reported any positive test results for the bacteria Clostridium botulinum in the recalled formula, but the precautionary recall aims to protect infants from potential harm. The FDA stated the recall does not create shortage concerns for parents and caregivers.
Nara Organics has issued a recall of its Whole Milk Organic Powdered Infant Formula sold at Target and online due to a multistate outbreak of infant botulism. The U.S. Food and Drug Administration announced that three infants, aged 2 to 5 months, were hospitalized in California, Pennsylvania, and Washington after consuming the product. The formula is manufactured in Europe and constitutes less than 1% of all infant formula sold in the United States.
Infant botulism is a rare but serious illness that affects babies under one year old, whose digestive systems are not fully developed. The condition arises when infants ingest bacteria spores that produce toxins in their intestines. Symptoms include constipation, poor feeding, drooping eyelids, weak muscle tone, and difficulty swallowing. The only treatment for infant botulism is BabyBIG, an intravenous medication derived from the blood plasma of immunized individuals.
The Centers for Disease Control and Prevention has urged consumers to stop using the recalled formula immediately. Caregivers are advised to take a photograph of the opened product, record the lot number and use-by date, and monitor infants for symptoms. The affected product lots are 709125280E14F2, 709125288E14F2, and 708125174E14F2. If no symptoms develop within a month, caregivers should discard the formula.
Nara Organics is cooperating with the FDA, CDC, and state health authorities to investigate the outbreak's cause. The company stated it is taking "aggressive action" to ensure the safety of its customers. Consumers who purchased the formula from Nara.com between May and June 2026 will receive an automatic refund. Those who bought the product at Target can return it for a refund or request one through the retailer's website.
This recall follows a previous outbreak of infant botulism linked to another brand, ByHeart, which resulted in over 50 illnesses across 19 states. While the current recall does not suggest a shortage of infant formula, it raises ongoing concerns about the safety of products available to parents and caregivers. The FDA has not reported any positive test results for the bacteria Clostridium botulinum in the recalled formula, but the precautionary recall aims to protect infants from potential harm.
As parents navigate the complexities of infant nutrition, awareness of product safety remains crucial. Caregivers should remain vigilant and informed about the products they choose for their children.
Highlighted text was flagged by the council. Tap to see feedback.
